Kiora Pharmaceuticals, Inc.
KPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $3,595 | -$12,514 | -$13,584 | -$13,771 |
| Dep. & Amort. | $19 | $52 | $42 | $45 |
| Deferred Tax | -$289 | $90 | -$113 | -$193 |
| Stock-Based Comp. | $657 | $755 | $462 | $842 |
| Change in WC | $3,666 | -$1,822 | $669 | -$1,036 |
| Other Non-Cash | $911 | $3,882 | $2,096 | $3,436 |
| Operating Cash Flow | $8,559 | -$9,557 | -$10,428 | -$10,675 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | $0 | $0 | -$64 |
| Net Acquisitions | $0 | $0 | $0 | -$93 |
| Inv. Purchases | -$35,632 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $12,976 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $6 | $0 |
| Investing Cash Flow | -$22,663 | $0 | $6 | -$157 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$212 |
| Stock Issued | $14,999 | $6,967 | $5,378 | $17,745 |
| Stock Repurch. | $0 | $0 | -$16 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $499 | -$1,001 | $3,259 | $50 |
| Financing Cash Flow | $15,498 | $5,966 | $8,621 | $17,583 |
| Forex Effect | -$57 | $36 | -$85 | -$82 |
| Net Chg. in Cash | $1,337 | -$3,555 | -$1,886 | $6,669 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,459 | $6,014 | $7,900 | $1,231 |
| End Cash | $3,796 | $2,459 | $6,014 | $7,900 |
| Free Cash Flow | $8,553 | -$9,557 | -$10,428 | -$10,739 |